ROCKET PHARMACEUTICALS INC (RCKT)
US77313F1066 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 55.90M | 140.50M | 232.70M | 297.10M | 185.40M | |||
| Marketable Securities | 317.27M | 215.90M | 156.00M | 185.60M | 118.70M | |||
| Other Current Assets | 5.05M | 7.70M | 3.30M | 4.60M | 3.60M | |||
| Total Current Assets | 378.22M | 364.10M | 392.10M | 487.30M | 307.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 87.59M | 77.60M | 72.30M | 70.60M | 31.60M | |||
| Investments And Advances | 34.32M | 43.30M | N/A | N/A | 0.00 | |||
| Goodwill | 39.15M | 39.20M | 30.80M | 30.80M | 30.80M | |||
| Intangibles | 25.15M | 25.70M | N/A | N/A | N/A | |||
| Other Non-Current Assets | 1.91M | 1.90M | 1.80M | 2.00M | 2.00M | |||
| Total Non-Current Assets | 188.12M | 187.70M | 104.90M | 103.50M | 64.30M | |||
| TOTAL ASSETS | 566.34M | 551.80M | 497.00M | 590.80M | 372.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 1.79M | 1.70M | 1.70M | 6.50M | N/A | |||
| Accrued Expenses | 31.80M | 35.20M | 20.00M | 25.30M | 18.00M | |||
| Accounts Payable | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Liabilities | 14.91M | 2.30M | 500.00K | 800.00K | 300.00K | |||
| Total Current Liabilities | 48.51M | 39.20M | 22.20M | 32.60M | 18.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 19.35M | 19.30M | 19.10M | 54.10M | 45.00M | |||
| Other Non-Current Liabilities | 5.91M | 3.70M | 1.00M | 600.00K | 1.50M | |||
| Total Non-Current Liabilities | 25.26M | 22.90M | 20.10M | 54.70M | 46.50M | |||
| TOTAL LIABILITIES | 73.77M | 62.10M | 42.30M | 87.30M | 64.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -959.37M | -713.80M | -491.90M | -322.80M | -183.10M | |||
| Additional Paid In Capital | 1.45B | 1.20B | 946.20M | 825.80M | 489.90M | |||
| Common Shares | 903.00K | 800.00K | 600.00K | 600.00K | 500.00K | |||
| Treasury Stock | 0.00 | 0.00 | N/A | 0.00 | -100.00K | |||
| Other Shareholders' Equity | 319.00K | -400.00K | -200.00K | 0.00 | 0.00 | |||
| Shares Outstanding | 90.28M | 79.10M | 64.50M | 61.00M | 54.80M | |||
| Tangible Book Value per Share | 4.74 | 5.37 | 6.57 | 7.75 | 5.05 | |||
| Total Shareholders' Equity | 492.57M | 489.70M | 454.70M | 503.50M | 307.30M | |||
| TOTAL LIABILITIES AND EQUITY | 566.34M | 551.80M | 497.00M | 590.80M | 372.10M | |||
| Statistics | ||||||||
| Debt/Equity | 0.04 | 0.04 | 0.04 | 0.11 | 0.15 | |||
| Current Ratio | 7.80 | 9.29 | 17.66 | 14.95 | 16.82 | |||
| Return On Assets (ROA) | -43.37% | -40.21% | -34.02% | -23.65% | -20.77% | |||
| Return On Equity (ROE) | -49.86% | -45.31% | -37.18% | -27.75% | -25.14% | |||
All data in USD